您的位置:
首页
>
农业专利
>
详情页
Use of Thymosin 1, alone or in combination with PTX3 or Ganciclovir, for the treatment of Cytomegalovirus infection.
专利权人:
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
发明人:
ROMANI, LUIGINA,BISTONI, FRANCESCO,GARACI, ENRICO
申请号:
DK07728041
公开号:
DK2012816T3
申请日:
2007.04.12
申请国别(地区):
DK
年份:
2012
代理人:
摘要:
It is described the use of thymosin alpha 1 in combination with long pentraxin PTX3 or Ganciclovir, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关专利
USE OF THYMOSIN 1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION
USE OF THYMOSIN 1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION
USE OF THYMOSIN α1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION
USE OF THYMOSIN α1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION
Use of thymosin alpha1, alone or in combination with PTX3 or Ganciclovir, for the treatment of cytomegalovirus infection